Legal Representation
Attorney
Olivia Maria Baratta
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 4, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 17, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 17, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 8, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 1, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of hyperinsulinism; pharmaceutical preparations for insulin disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Pharmaceutical research; pharmaceutical development; pharmaceutical testing; providing information related to healthcare, health conditions, and pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word REZOLUTE in a stylized font to the left of a flower design.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044